Literature DB >> 26034478

Eosinophilic fasciitis associated with myositis.

Yuko Adachi1, Yoko Mizutani1, En Shu1, Hiroyuki Kanoh1, Tatsuhiko Miyazaki2, Mariko Seishima1.   

Abstract

Eosinophilic fasciitis is clinically characterized by symmetrical scleroderma-like indurations of the skin with pain. The histological features are fascial inflammation with lymphocytes and eosinophils as well as thickened and fibrotic fascia. Lymphocytic infiltration and degeneration of the underlying muscle are rarely observed. We report a 69-year-old Japanese woman who presented with multiple areas of glossy induration and painful peau d'orange-like lesions on the chest and four extremities. T2-weighted magnetic resonance imaging showed significant hyperintense thickening of the fascia of the lower extremities. Histopathological examination of a biopsy specimen from the induration showed marked fibrinoid degeneration of the fascia and the neighboring muscle with mixed cellular infiltration of lymphocytes and eosinophils. The predominant CD8+ lymphocytic infiltrates were observed by immunohistological study. A diagnosis of eosinophilic fasciitis with myositis was made. Oral administration of prednisolone and discontinuation of exercise significantly improved the lesions and pain.

Entities:  

Keywords:  Eosinophilic fasciitis; Exercise; Magnetic resonance imaging; Myositis

Year:  2015        PMID: 26034478      PMCID: PMC4448070          DOI: 10.1159/000381845

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Eosinophilic fasciitis, first described by Shulman in 1975 [1], is a rare scleroderma-like disease characterized by symmetrical and painful swelling with progressive indurations and thickening of the skin [2]. Extracutaneous manifestations may rarely occur and include symmetrical polyarthritis, tenosynovitis, esophageal dysmotility, pulmonary fibrosis, pericarditis and hematologic diseases [3]. Eosinophilic fasciitis sometimes appears after intense physical exertion. The characteristic histological features are fascial inflammation with lymphocytes and eosinophils as well as thickened and fibrotic fascia. The inflammation and fibrosis may extend to the lower dermis, but lymphocytic infiltration and degeneration of the underlying muscle are rarely observed. We report a patient working as a yoga instructor who developed eosinophilic fasciitis on the chest and extremities histologically associated with myositis.

Case Report

A 69-year-old Japanese woman, who had practiced yoga for 30 years and had worked as a yoga instructor for the past 2 years, noticed induration of the skin on her chest for 13 months prior to consultation. She also noted exertional pain in the indurated areas, and the number and size of the skin lesions gradually increased. She denied fever, arthralgia, cough and Raynaud's phenomenon. She had no history of l-tryptophan or toxic oil product ingestion or statin medication use. On initial consultation, multiple areas of glossy induration (fig. 1a) and painful peau d'orange-like lesions (fig. 1c) were observed on the chest and four extremities (fig. 1b). Raynaud's phenomenon, sclerodactyly, pitting ulcer on the fingers and nail fold bleeding were absent. Laboratory examination revealed eosinophilia (0.71 × 109/l, normal <0.45 × 109/l), but serum creatine kinase, myoglobin, aldolase, IgG, IgA and IgM levels were within the normal limits and antinuclear antibodies were negative. T2-weighted magnetic resonance imaging (MRI) showed significant hyperintense thickening of the fascia of the lower extremities (fig. 1d). Histopathological examination of a biopsy specimen from an area of induration showed marked fibrinoid degeneration of the fascia (fig. 2a) and the neighboring muscle (fig. 2b) with mixed cellular infiltration of lymphocytes and eosinophils. Immunohistochemistry manifested predominant CD8+ lymphocytic infiltrates (fig. 2c) as well as a limited number of CD4+ lymphocytes (fig. 2d). Eventually a diagnosis of eosinophilic fasciitis with myositis was made. Oral administration of prednisolone (0.5 mg/kg/day) and discontinuation of yoga significantly improved the lesions and pain. The prednisolone was gradually reduced to 0.3 mg/kg/day.
Fig. 1

a, c Areas of induration on the posterior thighs (arrows; a) and painful peau d'orange-like eruptions on the left upper arm (c). b Distribution of cutaneous induration (red color). d T2-weighted MRI showed significantly thickened fascia of the lower extremities (arrowheads).

Fig. 2

a, b Photomicrographs of the induration (hematoxylin and eosin stain; original magnification: a ×100, b ×200). Degeneration of the fascia (a) and muscle (arrows, b) with infiltration of lymphocytes and eosinophils were observed. c, d Immunohistochemical stains by antibodies to CD8 (c) and CD4 (d) showing predominant CD8+ T cell infiltration (original magnification: ×400).

Discussion

There are no universally accepted diagnostic criteria for eosinophilic fasciitis. According to the diagnostic criteria proposed by Pinal-Fernandez et al. [4], the patient fulfilled two major criteria, including clinical features and histological findings, and three minor criteria, including eosinophilia >0.5 × 109/l, Groove sign and/or peau d'orange findings, and a hyperintense fascia on T2-weighted MRI. In addition, systemic sclerosis was excluded on the basis of clinical features, laboratory data and histological findings. Thus, a diagnosis of eosinophilic fasciitis was made. However, hypergammaglobulinemia, muscle weakness and elevated aldolase levels were not observed. Eosinophilic fasciitis is histologically characterized by a fibrous and inflammatory thickening of subcutaneous septa, fascia and the perimysial collagenous scaffold [5]. Macrophages and CD8+ T lymphocytes are reported to be the predominant cells in the inflammatory infiltrate. Some CD8+ lymphocytes contain granzyme B, suggesting a cytotoxic cellular immune response in eosinophilic fasciitis, which could be triggered by infectious or environmental agents. Although eosinophil infiltrates are present in 69–75% of patients with eosinophilic fasciitis [4], they may be absent at the chronic stage and are not essential for the diagnosis [6, 7]. In our patient, CD8+ T lymphocytes and eosinophils were present in the infiltrate. Eosinophils infiltrating the fascia degranulate locally, resulting in release and accumulation of cationic granules with toxic and potentially fibrogenic properties in the tissues [4]. In the patient with both eosinophilic fasciitis and eosinophilic cellulitis, an abnormal circulating T cell clone and increased interleukin 5 production have been observed, suggesting that this phenomenon might be responsible for eosinophilia and eosinophil-mediated tissue injury [3]. Interstitial myositis has been observed in 68% of patients with eosinophilic fasciitis [8], but clinical myositis and muscle degeneration are rarely reported [2]. In the present case, muscle degeneration and inflammatory cell infiltrate involving the muscle were observed. In our case the degree of myositis was limited, and serum creatine kinase, aldolase and myoglobin levels were within normal ranges. In some cases of eosinophilic fasciitis, elevated creatine kinase levels [8] and abnormal electromyographic changes have been reported [5]. MRI of the involved muscle is considered useful for diagnosis of eosinophilic fasciitis [9]. Typically, in the acute phase of the disease, muscle MRI shows a markedly increased signal intensity within the fascia on fluid-sensitive sequences and a remarkable fascia enhancement after gadolinium administration in up to 80% of patients [10]. In the present case, MRI of the lower extremities showed a significant hyperintense, thickened fascia. Thus, MRI is recommended for the diagnosis of eosinophilic fasciitis. Involvement of the trunk and morphea-like skin lesions are recognized risk factors for the development of persistent fibrosis and resistance to therapies [7]. In spite of a good response to systemic steroid therapy thus far, long-term physical therapy and follow-up are needed in the present patient, who had both truncal involvement and morphea-like skin lesions. Eosinophilic fasciitis can be triggered by drugs, toxic exposure, physical exertion, bacterial infection and associated diseases such as autoimmune diseases, hematologic diseases and solid neoplasms. Among these, 30–46% of eosinophilic fasciitis patients have a history of intense physical exertion or trauma associated with the onset of the disease [2, 6]. The present patient had practiced yoga for 30 years and had been a yoga instructor for 2 years before the onset of symptoms. In yoga, individuals maintain specific postures and perform exercises involving stretching of the extremities and bending of the trunk and/or extremities. The exercises are usually synchronized with breathing and are practiced by many for health and relaxation. There have been no previous reports of eosinophilic fasciitis induced by yoga. Although the affected area of the skin overlaid muscles being exercised in the present case, it is unclear whether the skin eruptions were caused by exercise.

Disclosure Statement

The authors declare that they have no conflict of interest and received no funding.
  10 in total

1.  From diagnosis to remission: place of MRI in eosinophilic fasciitis.

Authors:  Alexandra Desvignes-Engelbert; Norbert Saulière; Damien Loeuille; Alain Blum; Isabelle Chary-Valckenaere
Journal:  Clin Rheumatol       Date:  2010-06-10       Impact factor: 2.980

2.  Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa.

Authors:  Lars E French; Michael Shapiro; Jacqueline M Junkins-Hopkins; Jonathan T Wolfe; Alain H Rook
Journal:  J Am Acad Dermatol       Date:  2003-12       Impact factor: 11.527

3.  Diffuse fasciitis with eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  Trans Assoc Am Physicians       Date:  1975

4.  Eosinophilic fasciitis and myositis: use of imaging modalities for diagnosis and monitoring.

Authors:  F Dybowski; E Neuen-Jacob; J Braun
Journal:  Ann Rheum Dis       Date:  2008-04       Impact factor: 19.103

5.  Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.

Authors:  David Lebeaux; Camille Francès; Stéphane Barete; Bertrand Wechsler; Odile Dubourg; Jérôme Renoux; Thierry Maisonobe; Olivier Benveniste; Marc Gatfossé; Pierre Bourgeois; Zahir Amoura; Patrice Cacoub; Jean-Charles Piette; Damien Sène
Journal:  Rheumatology (Oxford)       Date:  2011-11-25       Impact factor: 7.580

6.  In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis.

Authors:  Claire Toquet; Mohamed Amine Hamidou; Karine Renaudin; Anne Jarry; Phryné Foulc; Sébastien Barbarot; Christian Laboisse; Jean-Marie Gilbert Mussini
Journal:  J Rheumatol       Date:  2003-08       Impact factor: 4.666

Review 7.  Eosinophilic fasciitis (Shulman disease).

Authors:  David Lebeaux; Damien Sène
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-08       Impact factor: 4.098

Review 8.  Diagnosis and classification of eosinophilic fasciitis.

Authors:  I Pinal-Fernandez; A Selva-O' Callaghan; J M Grau
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

Review 9.  Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.

Authors:  Lindsay Bischoff; Chris T Derk
Journal:  Int J Dermatol       Date:  2008-01       Impact factor: 2.736

Review 10.  Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.

Authors:  Yukie Endo; Atsushi Tamura; Youichiro Matsushima; Tomoko Iwasaki; Michiko Hasegawa; Yayoi Nagai; Osamu Ishikawa
Journal:  Clin Rheumatol       Date:  2007-03-08       Impact factor: 3.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.